The company reported Rs 164 crore in net profit in Q2FY22. Revenues dropped 12% YoY to Rs 1475 crore in Q2FY23 compared to Rs 1313 crore la...

The decision has been taken in order to curb the sales of spurious medicines. Furthermore, this will also help in checking the authenticity...

The widely-used drug saw sales soar 20X during the third wave of the pandemic. It registered a 100% jump in January over the previous month...

The chief medical nodal officer of the UT, Avijit Roy, told ET that the patients, who returned to Port Blair via Kolkata on March 24, have ...

The Gujarat-based firm has filed a plea with the Department of Pharmaceuticals, saying it doesn't agree with the manner in which the price ...

Alembic Pharmaceuticals posts 12% rise in Q2 net profit. Will add more to the basket of specialty products for growth.

During Q1, the company faced de-growth in its international generic formulation, while at domestic front, the company forayed into dermatol...

Alembic today posted 18% rise in PBT at Rs 53.54 cr for the quarter ended Dec 31, 2011 against Rs 45.40 cr in the corresponding quarter pre...

Alembic Pharmaceuticals, the newly-listed subsidiary of the 104-year Vadodara-headquartered group, will invest Rs 100 crore in a drugs faci...

Alembic Pharmaceuticals has posted 34% rise in net sales in its first quarter result after being carved out of Alembic Ltd.